|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项 ( w+ T$ ^* P$ C: y6 C( l9 c% {
01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.# n+ g) H' u0 C, Q3 z4 l8 i2 _3 I
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ s! g) G$ @% l3 u1 `' @
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.
4 o" t; R' `! K: b: w" i04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
5 \( Y+ E0 Y5 u7 f; q05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.
; x% x4 ~7 |* [0 R7 G; C! `06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
4 U4 L1 j: L/ o8 l6 u07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.1 N+ I0 F# `1 I0 O" t3 h
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.
' W X1 E! w) ]0 w09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
4 f; Q1 n# \, c/ {1 e3 G10.Interpretable machine learning for prostate biopsy: Cohort study.( ?2 f, ]$ J! c3 I
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.
! I1 `% o& L4 B& D9 Z8 g3 t5 ^12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.. e8 r6 X0 ]' q! Q, N
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
( N) F: ]3 {2 r" Q" z14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03)., v2 u6 o3 J- c e
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
6 @: L; V8 A; Q1 n1 N1 W) }7 @ `16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
( e8 x3 l" r a8 o17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.
- ~4 W5 R! S/ P6 }* B18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift./ F7 Y+ l7 s1 F- h4 v- |; Q1 ^
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.9 s* Z- D# C; K, v- e$ o) r" F
20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
+ T" O& b4 j% B! z; s2 C21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
) x, G& l1 |$ g) b8 H& l; I22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
: b3 S( T2 c: @$ C7 v23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.% f2 W- }. w t: B2 e9 J: ^& y: J
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis., Z# ?8 Z5 j3 \& E2 m& y
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.3 c I8 L2 M* Z5 t
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
